Show simple item record

dc.rights.licenseCC-BY-NC-ND
dc.contributor.advisorPieters, Roland
dc.contributor.authorMarkink, Job
dc.date.accessioned2024-10-31T01:02:11Z
dc.date.available2024-10-31T01:02:11Z
dc.date.issued2024
dc.identifier.urihttps://studenttheses.uu.nl/handle/20.500.12932/48047
dc.description.sponsorshipUtrecht University
dc.language.isoEN
dc.subjectComputer-Aided Drug Design (CADD) and Machine Learning (ML) are two fields that are constantly developing and are starting to become an important part of drug discovery. This review will focus on Structure-Based Drug Design and Ligand-Based Drug Design virtual screenings as techniques for CADD and looks at how ML can be incorporated in the drug discovery process. In addition, limitations of these fields and their future opportunities will be discussed.
dc.titleComputer Based Drug Design and Machine Learning for the Computational Search of Novel Carbohydrate Binding Protein Inhibitors.
dc.type.contentMaster Thesis
dc.rights.accessrightsOpen Access
dc.subject.courseuuDrug Innovation
dc.thesis.id40664


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record